skip to main content
Menu
Back to Top

Last updated March 22, 2022

The COVID-19 Resource Canada Site

Funding opportunities

 

The Michael J. Fox Foundation for Parkinson’s Research | Translational pipeline program

Pre-proposal deadline: April 26, 2022 17:00 ET
Funding available: $250,000 - $2 million (greater funding may be considered) 

Funding will support projects that aim to: advance early-stage targets with preliminary rationale for PD pathophysiology and/or symptomology into preclinical therapeutic development by using potent and selective tool compounds to demonstrate therapeutic potential; advance pre-clinical identification, validation or development of novel approaches and/or new interventions; repurpose or reposition approved or clinically safe therapies from other disease indications; progress promising interventions into initial Phase I trials to assess pharmacokinetics/pharmacodynamics and early safety/tolerability.

While programs developing treatments addressing underlying biology and a range of symptoms are encouraged to apply, MJFF is particularly interested in efforts that address moderate-to-advance motor, as well as non-motor and autonomic dysfunction symptoms. These include gait and balance issues, cognitive changes, sleep disturbances, pain and fatigue and mood disorders.  

More information


The Michael J. Fox Foundation for Parkinson’s Research | Biomarkers to support therapeutic trials program

Pre-proposal deadline: April 26, 2022 17:00 ET

Funding available: Up to $300,000 for up to two years

This program supports biomarkers research that will develop, optimize or analytically validate new or existing outcome measures to directly inform and transform therapeutic development in Parkinson’s disease. More information


The Michael J. Fox Foundation for Parkinson’s Research | Novel PET tracer development program

Pre-proposal deadline: April 26, 2022, 17:00 ET
Funding available: Up to $500,000 for up to two years

This program supports work to develop and validate PET imaging techniques utilizing radiotracers of a variety of disease-relevant targets that can ultimately be implemented in clinical practice and clinical trials. More information


Ontario Provincial Government | Seniors Community Grant Program

Application deadline: April 28, 2022, 5 p.m. ET
Funding available: Up to $25,000

Seniors Community Grants ranging from $1,000 up to $25,000 help community organizations provide opportunities for greater social inclusion, volunteerism and community engagement for older adults, from the safety of their homes or other safe environments. Projects can be focused on a number of areas.

Examples include: volunteerism, learning, financial awareness, social inclusion, elder abuse prevention, mental well-being, and physical activity. Programming can be delivered remotely, virtually, or in-person with proper health control measures in place. With the health and safety of Ontario’s older adults being more important than ever, the goal of the program is to address social isolation and help older adults stay healthy, safe and engaged in their communities. More information


The Future of Canada Project | Research Grants

Application deadline: May 2, 2022
Funding available: $150,000 for one year

The Future of Canada Project (FCP) was established in 2020 to support and amplify new, interdisciplinary research that has the power to foster dialogue and shape public discourse and policy. The Project will provide funding opportunities for research at McMaster University with a vision focused on building a better future for Canada and a brighter world — one that is more equitable, sustainable, resilient, and prosperous.

We are seeking proposals from McMaster researchers that engage one or more of the five themes selected for 2022 and articulate the potential to impact one or more of the elements identified in the Council’s vision of Canada’s future.

More information


Arthritis Society | Ignite Innovation Grant

Eligibility: Canada
Application registration deadline: May 16, 2022 17:00
Full application deadline: May 17, 2022
Funding available: Up to $50,000 annually for up to two years ($100,000 total)

The goal of the Ignite Innovation program is to support the development and testing of transformative, paradigm-shifting, concepts and approaches to address critical barriers to progress in arthritis research, challenge our understanding of arthritis and its management, and generate novel approaches to confront the challenges we face in defeating arthritis and delivering the best evidence-informed care possible. The program intends to foster novel, high-potential projects and ideas that could be expanded in the future through additional funding sources (i.e., successful operating grants, industry partnership programs, cross discipline funding opportunities, etc.). Successfully funded Ignite Innovation projects are based on “high risk” ideas that have a strong potential for “high reward”. The scope of high-risk projects could include proposals that focus on novel or untested tool development, cellular pathways, behavioural or psychosocial methodologies, research to address or ameliorate social or structural inequities, novel methods for delivering evidenced-based treatment or self-care interventions, unconventional devices or techniques/procedures (including measures) and/or have potential for unique translation.

More information


Arthritis Society | Stars career development award

Eligibility: Canada
Abstract registration deadline: May 18, 2022, 17:00 ET
Funding available: $125,000 annually for up to three years ($375,000 total), with an additional 3 years of support from the Host Institution of an equal value. The maximum amount per award for mid career investigators is $150,000 annually for up to 3 years, with an additional 3 years of support from the Host Institution of an equal value. These awards are non-renewable.

More information


Global Alliance for Chronic Disease | A life course approach to common noncommunicable disease risk factor prevention and reduction

Application deadline: May 31, 2022

The GACD seeks to fund collaborative, multidisciplinary and cross-cultural teams. The teams should include appropriate expertise in implementation research. Other eligibility requirements differ for each funding agency, and can be found in the agency-specific information listed on this page.

While only qualified researchers (as defined by individual agencies) can apply for this funding opportunity, collaboration with stakeholders, such as community and patient groups, local policymakers, public and clinical health professionals, non-governmental organisation leaders and/or others whose organisations or communities might benefit from the research, is a requirement for this call. Non-researchers interested in this call should consult the ‘Partnering with researchers’ section below (found under the ‘Further Information and Resources’ banner).

More information 


National Institutes of Health and National Institute on Aging | Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: June 1, 2022
Funding available: $8 million to support up to 10 awards

This Funding Opportunity Announcement solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). More information


NIH | Early and Late-Stage Clinical Trials for the Spectrum of Alzheimer’s Disease/Alzheimer’s Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)

Application deadline: June 5, 2022; October 5, 2022; February 5, 2023; June 5, 2023; October 5, 2023; February 5, 2024; June 5, 2024; October 5, 2024
Funding available: See funding call

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite applications that propose to develop and implement early to late stage clinical trials of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related Dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. More information


National Institutes of Health and National Institute on Aging | Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: June 15, 2022
Funding available: $5 million to support up to 10 awards

The goal of this Funding Opportunity Announcement is to stimulate research in noncoding RNAs (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This FOA supports applications seeking to discover novel mechanisms mediated by ncRNAs and to elucidate molecular and cellular functions involved in the pathogenesis and progression of AD/ADRD. More information


National Institutes of Health and National Institute on Aging | Noncoding RNAs in Alzheimer’s Disease and Related Dementias (R21 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: June 15, 2022
Funding available: $1 million to support up to 5 awards

The goal of this Funding Opportunity Announcement is to stimulate research in noncoding RNAs (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This FOA supports exploratory and developmental grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.

More information


Canadian Longitudinal Study on Aging (CLSA): Call for proposals  

Application deadline: June 15, 2022, 11:59 p.m. ET   
Funding available: MIRA can cover access fees ($3,000) for up to 10 CLSA data applications annually.  

MIRA members are eligible for support in accessing CLSA data, a national database tracking 50,000 Canadians aged 45 to 85 over a period of 20 years. Data access applications are accepted four times per year. Researchers should notify MIRA at mirafund@mcmaster.ca prior to applying for CLSA data access to be considered for funding. MIRA funds will be allocated only to projects that do not have any other funding for this purpose Learn more about this CLSA funding opportunity. See more details about free access to CLSA data for graduate and postdoctoral students 


NIH | Pilot Studies for the Spectrum of Alzheimer’s Disease/Alzheimer’s Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)

Application deadline: June 17, 2022; October 18, 2022; February 17, 2023; June 19, 2023; October 18, 2023; February 20, 2024; June 18, 2024; October 18, 2024
Funding available: See funding call

The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. More information


National Institutes of Health and National Institute on Aging | Inter-Organelle Communication as a Platform to Interrogate the Interactions of Hallmarks of Aging (R01 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: September 11, 2022
Funding available: $2.5 million for 5 to 6 awards

This Funding Opportunity Announcement encourages innovative, mechanistic approaches to identify and characterize interactions of aging hallmarks shaped by inter-organelle communication. More information


National Institutes of Health and National Institute on Aging | Mapping Interconnectivity Among Hallmarks of Aging under Lifespan Modifications (R01 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: September 11, 2022
Funding available: $2.4 million to fund 4 to 5 awards

This Funding Opportunity Announcement (FOA) solicits research projects with the goal of increasing our understanding of the interactions among hallmarks of aging and their regulation. Research supported by this FOA should explore the timing and possible priorities (hierarchy) among the hallmarks in various cells/tissues across the normal lifespan, and whether the interactions between the hallmarks are an adaptive response to maintain health at different stages of life. This is one of three inter-connected FOAs with an overarching focus on the interactions of aging hallmarks as a framework for innovative research in aging biology. More information


National Institutes of Health and National Institute on Aging | Studies of Cytosolic DNAs in the Interactions of Aging Hallmarks (R01 Clinical Trial Not Allowed)

Eligibility: International
Letter of intent deadline: September 11, 2022
Funding available: $2.56 million to fund 4 to 6 awards

This Funding Opportunity Announcement (FOA) invites applications on novel studies of the cytosolic DNA sensing mechanisms in the interactions of aging hallmarks. This FOA supports applications that will lead to an in-depth understanding of the molecular mechanisms that determine the effects of cytosolic DNAs on aging hallmarks in the context of aging and longevity. Research supported by this FOA should lead to new insights to address some critical mechanistic questions relevant to the role of aging hallmarks in aging and aging-related diseases. This FOA encourages innovative, mechanistic approaches to identify and characterize interactions of aging hallmarks mediated by cytosolic DNAs that ultimately modulate the regulation of healthspan and/or longevity. More information


National Institutes of Heath and National Institute on Aging | Pragmatic trials for dementia care and caregiver support (R61/R33 – Clinical trial required)  

Application deadline: October 11, 2022; February 10, 2023; October 10, 2023; February 13, 2024
Funding available: Up to $500,000 across two years 

This grant will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care.

More information about pragmatic trials for dementia care and caregiver support


National Institutes of Heath and National Institute on Aging | Dementia care and caregiver support intervention research (R01 – Clinical trial required)

Application deadline:  October 11, 2022; February 10, 2023; October 10, 2023; February 13, 2024
Funding available: Application budgets are not limited but need to reflect the actual needs of the proposed project.

This grant mechanism-focused dementia care and caregiver support intervention supports development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this opportunity is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions.

More information on dementia care and caregiver support intervention research


Canadian Statistical Sciences Institute | Ontario Data Access Grants

Application deadline: Rolling
Funding available: Up to 5,000

These grants of up to $5,000 cover costs associated with accessing and working with large data sources, which are necessary to carry out data-intensive research and application. The purpose of these grants is to foster research by mitigating the high cost of access to many data sets. Applications will be accepted on a rolling basis until two grants have been funded in a given academic year.

More information about Ontario data access grants


Global Cardiovascular Research Funders Forum (GCRFF): Multinational Clinical Trials

Expression of interest deadline: Rolling
Funding available: Awarded funds will vary based on project need.

The trial should plan to test specific interventions or pathways of care for the prevention, diagnosis or
treatment of heart and circulatory diseases. Interventions include drugs, surgery, devices, psychological, physical and educational interventions. The trial should address an unmet clinical need of importance to people affected by, or at risk of, cardiovascular disease. Its results should have the potential to change clinical practice. There should be a clear need for a multinational trial to answer the clinical question.

More information about global cardiovascular research funding forum


Birks Family Foundation Grant

Application deadline: Rolling (apply six months prior to when funds would be required) 
Funding available: Application dependent

The Birks Family Foundation funds organizations either primarily focused on Quebec, or those whose work is broadly national in nature; Public sector organizations, including universities, hospitals, libraries and museums; Projects that demonstrate unique innovation in their field and/or pioneer state-of-the-art technology; Long range projects designed to become self-sustaining; and, organizations that actively engage directly with their target group through programs and/or services. 

More information about the Birks Family Foundation grant


Max Bell Foundation Grant

Application deadline: Rolling
Funding details: Apply for the amount of money that you need to complete your project. Be aware that Max Bell Foundations generally funds 30-60% of a project and prefers to fund projects that have other funders.

The foundation prefers to collaborate with applicants to create final project proposals. Proposals should focus on development of forward-looking innovations that impact public policies and practices with an emphasis on health and wellness, education, and the environment.

More information about the Max Bell Foundation grant


NSERC Alliance

Application deadline: applications are currently being accepted for Option 1 and 2
Funding available: $20,000 to $1,000,000 per year for one to five years

NSERC Alliance grants encourage university researchers to collaborate with partner organizations, which can be from the private, public or not-for-profit sectors. Funding may support research and development projects that seek to respond to a research challenge in the natural sciences or engineering, while working with external partners who are able to accelerate scale-up, application, impact, or commercialization. NSERC is now accepting Option 1 applications requiring at least 50 per cent matching cash contributions from partner organizations, and for Option 2, involving non-profit partners and requesting 90 to 100 per cent funding support from NSERC.

More information about NSERC Alliance


Physician’s Services Incorporated (PSI) Foundation 

Clinical Research Grant

The PSI Clinical Research Grant is open to Post M.D. physicians looking to conduct research which is of direct relevance to patient care.

More information about Physician Services Incorporated Foundation Grants

Health Systems Research Grant

The Health Systems research grant funds projects of a special nature within the healthcare system, such as preventative medicine, care of the elderly, communications within the system, underserviced regions, and ways of enhancing the effectiveness of medical practice will be considered under this category. 

More information about Health Systems Research Grants

New Investigator Research Grant 

The New Investigator funding stream is open to Clinical Fellows or physicians within five years of their first academic appointment. 

More information about New Investigator Research Grants

Resident Research Grant 

Resident Research Grants are concise health research projects, which have been largely developed by the Resident. To be eligible to apply for a Resident Research Grant, the Resident must have PGY status as per the College of Physicians and Surgeons of Ontario. The restriction whereby PSI will not consider applications for research within the areas of cancer, and heart and stroke does not apply to resident research projects.

More information about Resident Research Grants

Healthcare Research by Community Physicians Grant 

To assist physicians practicing in a community setting to undertake a review of their practice patterns which would enhance effectiveness of practice and patient care in their own clinic, hospital, or region.

More information about Healthcare Research by Community Physicians Grants

Graham Farquharson Knowledge Translation Fellowship 

The PSI Graham Farquharson Fellowship is intended to provide salary support for a new investigator who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research.

More information about Graham Farquharson Knowledge Translation Fellowship

 
 
Email MIRA at: MIRAinfo@mcmaster.ca       Follow us on Twitter : @MIRAMcMaster
McMaster Footer Logo
Institute For Research On Aging Footer Logo

© 201​6 McMaster University  |  MIP Suite 109A, 1280 Main St. W., Hamilton, ON L8S 4K1  |  Contact Us  | Email UsTerms of Use & Privacy Policy